Literature DB >> 19915520

Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.

Péter Koncsos1, Ildikó Seres, Mariann Harangi, István Illyés, Lajos Józsa, Ferenc Gönczi, László Bajnok, György Paragh.   

Abstract

Childhood obesity is a predisposing factor for adult cardiovascular diseases. Human serum paraoxonase (PON1) may protect against atherosclerosis by hydrolyzing lipid peroxides in oxidized LDL. Alterations and potential correlations of PON1 activities, leptin and adiponectin levels in childhood obesity were studied. We measured PON1 paraoxonase and arylesterase activities, anthropometric parameters, leptin and adiponectin levels in 59 white, obese (obese group-OB: BMI corrected for age: 95.1 +/- 3.5 percentile, age: 11.9 +/- 1.6 y) and 51 normal-weight children (control group-C: BMI corrected for age: 64.1 +/- 8.4 percentile, age: 12.0 +/- 3.9 y). Obese children had significantly lower PON1 paraoxonase (OB: 84.80 (64.33/144.74) U/L versus. C: 99.42 (83.33/152.05) U/L; p < 0.05) and arylesterase activities (OB: 94.40 (82.20/108.70) U/L versus. C: 115.20 (93.70/126.00) U/L; p < 0.01), higher leptin (OB: 37.05 (24.33/53.87) ng/mL versus. C: 4.62 (2.52/17.6) ng/mL; p < 0.0001) and lower adiponectin levels (OB: 7.56 (5.69/12.06) microg/mL versus. C: 11.51 (8.84/14.49) microg/mL; p < 0.001) compared with the normal-weight group. PON1 arylesterase activity showed inverse univariate correlation with leptin (r = -0.29; p < 0.05) and positive correlation with adiponectin levels (r = 0.39; p < 0.01). In multiple regression analysis adiponectin was strongly associated with PON1 arylesterase activity in obese children (beta = 0.45, p < 0.02). Our results emphasize the importance of the investigated metabolic alterations which may have further effects on cardiovascular morbidity and mortality in later adulthood. Altered levels of leptin, adiponectin and PON1 activities may be useful markers beside the general risk factors in childhood obesity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19915520     DOI: 10.1203/PDR.0b013e3181c9fb66

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

Review 1.  Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health.

Authors:  Nina Holland; Daneida Lizarraga; Karen Huen
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

2.  Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study.

Authors:  Maria Fernanda Martínez-Salazar; Damianys Almenares-López; Sara García-Jiménez; Miguel Angel Sánchez-Alemán; Alina Juantorena-Ugás; Camilo Ríos; Antonio Monroy-Noyola
Journal:  Genes Nutr       Date:  2011-03-25       Impact factor: 5.523

Review 3.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

Review 4.  Future of environmental research in the age of epigenomics and exposomics.

Authors:  Nina Holland
Journal:  Rev Environ Health       Date:  2017-03-01       Impact factor: 3.458

5.  Associations of PON1 and genetic ancestry with obesity in early childhood.

Authors:  Karen Huen; Kim Harley; Kenneth Beckman; Brenda Eskenazi; Nina Holland
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

6.  Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome.

Authors:  Gianna Ferretti; Tiziana Bacchetti; Simona Masciangelo; Graziano Grugni; Virginia Bicchiega
Journal:  Dis Model Mech       Date:  2012-07-19       Impact factor: 5.758

Review 7.  Genetics of oxidative stress in obesity.

Authors:  Azahara I Rupérez; Angel Gil; Concepción M Aguilera
Journal:  Int J Mol Sci       Date:  2014-02-20       Impact factor: 5.923

8.  Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia.

Authors:  Sunil K Kota; Lalit K Meher; Siva K Kota; Sruti Jammula; S V S Krishna; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2013-05

9.  Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients.

Authors:  Péter Fülöp; Ildikó Seres; Hajnalka Lőrincz; Mariann Harangi; Sándor Somodi; György Paragh
Journal:  J Cell Mol Med       Date:  2014-04-06       Impact factor: 5.310

10.  Effects of a 12-week aerobic exercise on markers of hypertension in men.

Authors:  Behrouz Baghaiee; Pouran Karimi; Khadije Ebrahimi; Saeed Dabagh Nikoo Kheslat; Mohammad Hossein Sadeghi Zali; Amir Mohammad Daneshian Moghaddam; Mohammad Sadaghian
Journal:  J Cardiovasc Thorac Res       Date:  2018-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.